BTIG downgraded Accuray to Neutral from Buy without a price target. The company is ahead of schedule on its cost-cutting efforts, but its product revenue is being held back by geopolitical uncertainty and its adjusted EBITDA missed expectations again, the analyst tells investors in a research note. The firm says Accuray removed its 2026 guidance on geopolitical uncertainty in the Middle East. BTIG expects a lack of investor interest in the shares given Accuray's declining revenue, little visibility on a turnaround, and lack of predictable progress on profitability.
